Caribou Biosciences Raises $115M Series C Financing to Advance Next-Generation CRISPR Technologies and Allogeneic Cell Therapy Pipeline

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2Po9Ij0
via IFTTT